Unlocking the Potential of Patient-Reported Outcomes: Practical Uses in Routine Oncology Care

Abstract: A growing body of evidence supports the use of remote symptom monitoring based on patient-reported outcomes (PROs) to manage symptoms, improve quality of life, and […]

Converging Approaches in the Frontline Treatment of Mantle Cell Lymphoma

Abstract: Mantle cell lymphoma is a biologically and clinically heterogeneous subtype of non-Hodgkin lymphoma that affects predominantly older patients. The disease remains incurable with modern therapies. […]

The Use of PSMA PET/CT Imaging as an Endpoint in Clinical Trials of Prostate Cancer

H&O  In what clinical situations is the use of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) imaging well established?  MM  There are 3 approved […]

Antibody-Drug Conjugates in the Treatment of Lung Cancer

H&O  How much enthusiasm is there for antibody-drug conjugates (ADCs) in lung cancer? BL  There is a tremendous amount of enthusiasm for this class of compounds […]

Lessons Learned From the GAIA/CLL13 Trial in Chronic Lymphocytic Leukemia

H&O What was the rationale for designing the GAIA/CLL13 trial? MF We planned this study nearly 10 years ago, when continuous Bruton tyrosine kinase inhibitor therapy […]

Back to Archive